Treating Charles Bonnet syndrome: Understanding inconsistency [9]

Journal of Clinical Psychopharmacology

Volumn 20, Issue 3, 2000, Pages 396-

  Kornreich, C ^a   Dan, B ^a   Verbanck, P ^a   Pelc, I ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; PIMOZIDE; RISPERIDONE; SEROTONIN 2 ANTAGONIST;

AGED; CASE REPORT; CHARLES BONNET SYNDROME; CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; DRUG INDUCED DISEASE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SYSTEMIC DISEASE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; HALLUCINATIONS; HALOPERIDOL; HUMANS; MALE; PSYCHOTIC DISORDERS; RISPERIDONE; SYNDROME;

EID: 0034113606     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200006000-00025     Document Type: Letter

References (4)